Utilising Thrombin Generation Assay to Guide Co‐Administration of Factor Therapies With Fitusiran

Documenti analoghi

• In vitro combined haemostatic efficacy of emicizumab and extended half‐life factor VIII compounds
  di: Laurie Josset, et al.
  Pubblicazione: (2025)
• Haemophilia Prophylaxis in the Age of Innovation: Exploring Opportunities for Personalized Treatment
  di: Yesim Dargaud, et al.
  Pubblicazione: (2025)
• Voices of patients with hemophilia: Life‐changing gene therapy
  di: Genevieve Pietu, et al.
  Pubblicazione: (2024)
• Thrombin Generation Assay to Support Hematologists in the Era of New Hemophilia Therapies
  di: Laurie Josset, et al.
  Pubblicazione: (2024)
• Heterozygous large deletion mimicking homozygous substitution in MCFD2 in a patient with combined Factor V and Factor VIII deficiency
  di: Hamdi Rezigue, et al.
  Pubblicazione: (2024)